316.58
price down icon4.07%   -13.42
 
loading

Krystal Biotech Inc Azioni (KRYS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2.46%
119.22
116.36 107.11 97.80 96.04
Operating Expenses
2.97%
60.80
62.67 62.84 56.43 56.73
Operating Income/Loss
8.81%
58.42
53.69 44.27 41.37 39.31
Income/Loss From Continuing Operations Before Tax
7.55%
66.08
61.44 51.13 47.97 46.77
Income Tax Expense/Benefit
105.28%
11.31
5.51 -0.269 -31.40 8.442
Net Income/Loss
2.08%
54.77
55.93 51.40 79.36 38.33
Basic Average Shares
0.82%
29.53
29.29 0.051 28.95 28.91
Diluted Average Shares
0.49%
30.66
30.51 0.122 29.83 29.75
Basic Earnings Per Share
3.14%
1.85
1.91 1.77 2.74 1.33
Diluted Earnings Per Share
2.19%
1.79
1.83 1.70 2.66 1.29
$9.18
price down icon 8.20%
$132.75
price down icon 8.13%
$63.62
price down icon 2.53%
$104.78
price down icon 3.11%
CAI CAI
$30.56
price down icon 3.78%
$61.95
price down icon 3.08%
Capitalizzazione:     |  Volume (24 ore):